4592SanBio Company4592 info
$6.74info2.34%24h
Global rank12169
Market cap$441.76M
Change 7d-2.73%
YTD Performance31.42%
SP500 benchmarkOutperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    SanBio Company (4592) Stock Overview

    SanBio Company Limited develops, produces, and sells regenerative cell medicines for the central nervous system. The company develops SB623 that has completed a phase 2 clinical trial to treat traumatic brain injury in the United States and Japan. Its research pipeline products also comprise SB623 for ischemic and hemorrhagic strokes, age-related macular degeneration, retinitis pigments, Parkinson's disease, spinal cord injury, and Alzheimer's disease; SB618 for peripheral nerve damage; SB308 for muscular dystrophy disease; MSC1 for cancer; and MSC2 for inflammatory disease and optic neuritis. The company was founded in 2001 and is headquartered in Tokyo, Japan.

    4592 Stock Information

    Symbol
    4592
    Address
    St. Luke TowerTokyo, 104-0044Japan
    Founded
    -
    Trading hours
    -
    Website
    https://www.sanbio.com
    Country
    🇯🇵 Japan
    Phone Number
    81 3 6264 3481

    SanBio Company (4592) Price Chart

    -
    Value:-

    SanBio Company Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $6.74
    N/A
    Market Cap
    $441.76M
    N/A
    Shares Outstanding
    65.51M
    N/A
    Employees
    65.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org